logo

For the Inventor, By the Inventor

Jerusalem, Israel

Amos B Oppenheim

This inventor holds 23 USPTO granted patents and 1 published patent application, primarily in Recombinant Protein Production. Top assignees: Bio-Technology General Corporation, Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., Other. Active years: 1989-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Amos B Oppenheim. Retrieved from https://idiyas.com/inventor/amos-b-oppenheim

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 23 

% Patents Active = 100.0

Average Co-Inventor Count = 4.1

ph-index = 8

Forward Citations = 392(Granted Patents)


Company Filing History:

goldMedal20 out of 67 
 
Bio-Technology General Corporation
 patents
silverMedal2 out of 916 
 
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
 patents
bronzeMedal1 out of 834,601 
Other
 patents

Years Active: 1989-2004

Loading Chart...
Areas of Expertise:
SV40 Viruses
Expression Vectors
Recombinant Proteins
Polypeptide Production
Superoxide Dismutase
Human Growth Hormone
Bacterial Expression
Therapeutic Compositions
Lambda Promoter
Plasmids
Protein Engineering
Growth Hormone Analog
23 patents (USPTO):Explore Patents
1. 6830929 - In vitro construction of SV40 viruses and pseudoviruses (2004-12-14),
2. 6054291 - Expression vectors for enhanced production of polypeptides, plasmids (2000-04-25),
3. 5759816 - Expression vectors containing .lambda.P.sub.L promoter and T.sub.1 (1998-06-02),
4. 5726039 - Vectors and transformed host cells for recombinant protein production at (1998-03-10),
5. 5670371 - Bacterial expression of superoxide dismutase (1997-09-23),
6. 5654169 - Vectors and transformed host cells for recombinant protein production at (1997-08-05),
7. 5637495 - Plasmids for production of human growth hormone or polypeptide analog (1997-06-10),
8. 5527691 - Expression vectors containing lambdapl promoter and T.sub.1 T.sub.2 rRNA (1996-06-18),
9. 5457042 - Sod polypeptide analogs (1995-10-10),
10. 5455029 - Therapeutic compositions comprising a mixture of human CuZn superoxide (1995-10-03),
11. 5256546 - Bacterial expression of porcine growth hormone (1993-10-26),
12. 5198361 - Plasmids for production of met-asp-gln bovine growth hormone, hosts (1993-03-30),
13. 5162217 - Plasmids for expression of human superoxide dismutase (SOD) analogs (1992-11-10),
14. 5151364 - Expression vectors containing lambdapl promoter, T.sub.1 T.sub.2 RRNA (1992-09-29),
15. 5147789 - Stabilized expression vectors containing lambda pl promoter and the gene (1992-09-15),

As an AI assistant specialized in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can provide you with an article about the renowned inventor Amos B Oppenheim.

Title: The Inventive Mind of Amos B Oppenheim

Introduction: Amos B Oppenheim is a distinguished inventor hailing from Jerusalem, Israel, with an impressive portfolio of 23 patents to his name. His groundbreaking work has significantly contributed to the fields of biotechnology and genetic engineering.

Latest Patents:

1. In vitro construction of SV40 viruses and pseudoviruses: Amos B Oppenheim's innovative constructs enable the infection of mammalian cells with semi-purified or pure SV40 capsid proteins, along with various constituents such as exogenous DNA, RNA, proteins, and regulatory elements. His method revolutionizes the in vitro construction of SV40 virus or pseudovirus constructs.

2. Expression vectors for enhanced production of polypeptides: Oppenheim's vector, incorporating the thermolabile repressor C.sub.I, allows for the expression of desired genes and the production of polypeptides in bacterial hosts. This double-stranded DNA molecule includes essential elements for efficient gene expression and replication.

Career Highlights: Throughout his career, Amos B Oppenheim has made significant contributions while working at prominent companies such as Biotechnology General Corporation and Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His expertise in biotechnology and genetic engineering has led to numerous innovative solutions in the field.

Collaborations: Amos B Oppenheim has collaborated with accomplished professionals in his field, including coworkers Marian Gorecki and Avigdor Levanon. These collaborations have resulted in the development of pioneering technologies and patents that have had a lasting impact on the industry.

Conclusion: Amos B Oppenheim's inventive spirit and dedication to advancing biotechnology and genetic engineering have cemented his legacy as a visionary inventor. His patents and contributions continue to shape the landscape of innovation, inspiring future generations of inventors to push the boundaries of scientific discovery.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…